<p>This study cohort is composed of 287 patients affected by myeloid disease (AML/MDS) who were subjected to allogeneic hematopoietic cell transplantation (allo-HCT) from an HLA-matched related donor. For each study subject, we have collected genomic DNA from both donor and recipient (D-R). Resulting germline whole exome sequencing from D-R pairs has formed the basis for applying an analytical pipeline to systematically predict minor histocompatibility antigens (mHAgs) </p>

Systematic Identification of Minor Histocompatibility Antigens Informs    Outcomes after Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation study with WXS data on dbGaP (576 participants)

Systematic Identification of Minor Histocompatibility Antigens Informs Outcomes after Allogeneic Stem Cell Transplantation

Description

Applying For Access

Summary